Unknown

Dataset Information

0

TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization.


ABSTRACT: Background: Chagas cardiomyopathy is caused by Trypanosoma cruzi (Tc). Two antigenic candidates, TcG2 and TcG4, are recognized by antibodies in naturally infected dogs and humans; and these vaccine candidates provided protection from Tc infection in mice and dogs. Trypanosoma rangeli (Tr) is non-pathogenic to mammals and shown to elicit cross-reactive anti-Tc antibodies. In this study, we investigated if fixed Tr (fTr) can further enhance the efficacy of the TcG2/TcG4 DNA vaccine. Methods and Results: C57BL/6 mice were immunized with TcG2/TcG4 DNA vaccine and fTr (delivered as an adjuvant or in prime-boost approach), and challenged with Tc. Serology studies showed that fTr (±quil-A) elicited Tc- and Tr-reactive IgGs that otherwise were not stimulated by TcG2/TcG4 vaccine only, and quil-A had suppressive effects on fTr-induced IgGs. After challenge infection, TcG2/TcG4-vaccinated mice exhibited potent expansion of antigen- and Tc-specific IgGs that were not boosted by fTr±quil-A. Flow cytometry analysis showed that TcG2/TcG4-induced dendritic cells (DC) and macrophages (M?) responded to challenge infection by expression of markers of antigen uptake, processing, and presentation, and production of pro-inflammatory cytokines. TcG2/TcG4-induced CD4+T cells acquired Th1 phenotype and expressed markers that orchestrate adaptive immunity. A fraction of vaccine-induced CD4+T cells exhibited iTreg phenotype responsible for aversion of self-injurious immune responses. Further, TcG2/TcG4-vaccinated mice exhibited potent expansion of poly-functional CD8+T cells with TNF-?/IFN-? production and cytolytic phenotype post-infection. Subsequently, tissue parasites and pathology were hardly detectable in TcG2/TcG4-vaccinated/infected mice. Inclusion of fTr±quil-A had no clear additive effects in improving the Tc-specific adaptive immunity and parasite control than was noted in mice vaccinated with TcG2/TcG4 alone. Non-vaccinated mice lacked sufficient activation of Th1 CD4+/CD8+T cells, and exhibited >10-fold higher levels of tissue parasite burden than was noted in vaccinated/infected mice. Conclusion: TcG2/TcG4 vaccine elicits highly effective immunity, and inclusion of fTr is not required to improve the efficacy of DNA vaccine against acute Tc infection in mice.

SUBMITTER: Gupta S 

PROVIDER: S-EPMC6606718 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>TcG2/TcG4</i> DNA Vaccine Induces Th1 Immunity Against Acute <i>Trypanosoma cruzi</i> Infection: Adjuvant and Antigenic Effects of Heterologous <i>T. rangeli</i> Booster Immunization.

Gupta Shivali S   Salgado-Jiménez Berenice B   Lokugamage Nandadeva N   Vázquez-Chagoyán Juan Carlos JC   Garg Nisha Jain NJ  

Frontiers in immunology 20190626


<b>Background:</b> Chagas cardiomyopathy is caused by <i>Trypanosoma cruzi</i> (<i>Tc</i>). Two antigenic candidates, TcG2 and TcG4, are recognized by antibodies in naturally infected dogs and humans; and these vaccine candidates provided protection from <i>Tc</i> infection in mice and dogs. <i>Trypanosoma rangeli</i> (<i>Tr</i>) is non-pathogenic to mammals and shown to elicit cross-reactive anti-<i>Tc</i> antibodies. In this study, we investigated if fixed <i>Tr</i> (fTr) can further enhance t  ...[more]

Similar Datasets

2023-04-11 | GSE229354 | GEO
| S-EPMC5736184 | biostudies-literature
| S-EPMC3508390 | biostudies-literature
| S-EPMC6201504 | biostudies-literature
| S-EPMC7047160 | biostudies-literature
| S-EPMC193880 | biostudies-literature
| S-EPMC3891993 | biostudies-literature
| PRJNA954048 | ENA
| S-EPMC6435186 | biostudies-literature
| S-EPMC10891849 | biostudies-literature